The Miami CTSI Pilot Program awards innovative, interdisciplinary, health disparities-oriented and clinical translational science research proposals that clearly align with the CTSI goals of improving community health, addressing disparities, and promoting health equity. These projects are expected to generate publications and data for external funding.

As many as four meritorious projects of up to $40,000 each (for direct costs only), will be funded for fiscal year 2023. Funding is prioritized for projects that directly relate to health disparities, or address challenges in health areas that disproportionately affect minority health and/or underserved populations.

The award period is 12 months, with an estimated project period of March 1, 2023 – February 29, 2024 (start date subject to NIH/NCATS prior approval).

Please refer to the Funding Opportunity Announcement (FOA)  for complete details and requirements.

• The research supported by this program must be translational in nature. Basic research projects are not eligible. For detailed information, visit NCATS Translational Spectrum.
• Research projects conducted outside of the U.S. to any extent will not be considered.
• Only new applications and first resubmissions to any UM internal award mechanism are allowed.

All criteria must be met as of application due date on December 1, 2022.

• Only full-time faculty at the ranks of Assistant or Associate Professors are eligible to apply as Principal Investigators (PI). Full Professors may serve only as co-investigators or mentors.
• Jackson Health System and Miami VA full-time faculty may apply as PI, with at least one full-time UM faculty co-investigator.
• Residents, instructors, staff, post-doctoral and clinical fellows are not eligible
• Proposals submitted by women, individuals from disadvantaged backgrounds, and/or individuals from racial/ethnic groups underrepresented in sciences and medicine are encouraged. For more information, please visit NIH guidance on underrepresented groups in the extramural scientific workforce.

Review the Funding Opportunity Announcement (FOA) for complete details and requirements.

Proposal submission is electronic via CTSI FY23 Pilot Application.

Submissions that are incomplete or otherwise do not follow instructions both in this RFA and within the application will be considered unresponsive and will not be reviewed. Applicants/projects not meeting eligibility criteria will not be reviewed.

Have questions after reviewing the FOA? Check out our recorded Info Session here.

You may also email the program contacts below.

The Miami CTSI receives funding from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH).  Awarded pilot projects involving human subjects and/or live vertebrate animals must receive approval from NCATS prior to starting research (drawing down funds) and can only be obtained with valid IRB/IACUC/required regulatory approval documentation. NCATS Prior Approval typically takes a minimum of 30 days and awardees will work with the CTSI team to ensure prior approval requirements are met and documentation submitted.

Who to Contact

If you have questions about the pilot awards program, please contact:

• Dalton Dietrich, Ph.D., Director, Miami CTSI Pilot Translational and Clinical Studies Program [email protected]
• Melanie Weiss, MHA, Director, Research Operations, Miami CTSI [email protected]